Business Context and Reporting Period
This Form 8-K, dated October 20, 2020, reports on AMC Entertainment Holdings, Inc. (AMC). The filing details the entry into a new equity distribution agreement and provides an operating update as of October 16, 2020, alongside preliminary financial results for the three and nine months ended September 30, 2020.
Key Financial Metrics
Revenue and Expenses
- Q3 2020 Revenue: Approximately $119.5 million (vs. $1,316.8 million in Q3 2019).
- YTD 2020 Revenue: Approximately $1,079.8 million (vs. $4,023.3 million in YTD 2019).
- Q3 2020 Operating Costs: Estimated between $584.4 million and $604.4 million, excluding impairment charges (vs. $1,296.0 million in Q3 2019).
- Q3 2020 Interest Expense: Approximately $94.3 million (vs. $85.1 million in Q3 2019).
Liquidity and Cash Flow
- Cash and Cash Equivalents: Estimated at $417.9 million as of September 30, 2020.
- Recent Capital Raised: Approximately $54.7 million raised via a prior at-the-market offering, including $51.9 million post-September 30, 2020.
- Projected Cash Depletion: Management anticipates existing cash resources could be largely depleted by the end of 2020 or early 2021 without significant attendance increases or additional liquidity.
Debt and Impairments
- Impairment Charges: The Company expects to record material non-cash charges for the impairment of long-lived assets, indefinite-lived intangible assets, and goodwill, though specific amounts are not yet determined.
- Tax Attributes: A material non-cash deferred tax charge is expected due to the reduction of tax attributes (primarily net operating losses) following a debt exchange.
Material Changes vs. Prior Period
- Revenue Decline: Q3 2020 revenue represents a decrease of approximately 91% compared to the same period in 2019.
- Attendance Decline: Same-theatre attendance in the U.S. declined approximately 85% year-over-year; international same-theatre attendance declined approximately 74%.
- Operating Costs: Excluding impairments, operating costs decreased significantly year-over-year due to reduced operations, though depreciation and amortization increased slightly.
- Interest Expense: Interest expense increased year-over-year, reflecting higher debt service costs.
Guidance, Outlook, and Risks
Operational Outlook
- Theatre Reopenings: As of October 16, 2020, 519 of 598 U.S. theatres were open (87%) at 20-40% capacity. 309 international theatres were open (86%) at 25-50% capacity.
- Closed Locations: The remaining 13% of U.S. theatres, representing 20% of 2019 revenue, are primarily in California, Maryland, and New York. Twelve New York theatres were scheduled to open October 23, 2020.
- Content Slate: Major Q4 movie releases have been rescheduled to 2021 or moved to streaming, reducing the theatrical slate.
Liquidity and Going Concern
The Company has disclosed substantial doubt about its ability to continue as a going concern. It is actively exploring additional debt/equity financing, lease renegotiations, asset sales, and joint ventures. There is a significant risk that these sources will be insufficient, potentially leading to a restructuring or bankruptcy where common stockholders could suffer a total loss of investment.
New Initiatives
- Equity Offering: Entered an agreement to sell up to 15,000,000 shares of Class A common stock via an "at-the-market" program with Citigroup and Goldman Sachs.
- Private Screenings: Launched "AMC Private Screening" allowing groups of up to 20 to rent an auditorium starting at $99.
Investor Verification Checklist
- Verify the specific amounts of the anticipated non-cash impairment charges and deferred tax charges in the upcoming audited quarterly report.
- Monitor the timeline for reopening the remaining 13% of U.S. theatres, particularly in California, Maryland, and New York.
- Track the success of the new "at-the-market" equity offering and other liquidity initiatives to determine if they will prevent cash depletion by early 2021.
- Assess the impact of the reduced Q4 movie release slate on attendance recovery and revenue projections.
- Review the updated risk factors (Exhibit 99.1) regarding the substantial doubt on the going concern status.